Frontier
Copyright ©2013 Baishideng Publishing Group Co.
World J Transplant. Jun 24, 2013; 3(2): 7-25
Published online Jun 24, 2013. doi: 10.5500/wjt.v3.i2.7
Table 2 Withdrawal/conversion trials
Study (yr)DrugsF-up(mo)Patient survival
Graft survival
Biopsyproven acuterejection
Glomerular filtration rate (mL/min)
SRL/EVRCNISRL/ EVRCNISRL/EVRCNISRL/EVRCNI
RMR (2004)SRL (SRL+CsA)4895.3%92.1%91.5%84.2%10.26.558.343.8
Spare the Nephron (2011)SRL/CNI24100%97.5%100%98.7%9.511.359.558.8
CONCEPT (2009)SRL/CsA12100%100%100%99.0%16.88.269.664.8
SMART (2010)SRL/CsA1299.0%99%99.0%97.0%17.415.564.553.4
ZEUS (2012)EVR/CsA3698.1%97.9%98.7%98.6%13.04.867.960.6
HERAKLES (2012)EVR/CsA1299.4%98.8%99.4%99.4%10.08.468.663.0